NCT01572493 Continuous Infusion of rhIL-15 for Adults With Advanced Cancer Status COMPLETED Phase PHASE1
NCT01568632 Imetelstat for Children With Refractory or Recurrent Solid Tumors and Lymphoma Status WITHDRAWN Phase PHASE1
NCT01567722 Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies Status TERMINATED Phase N/A
NCT01563874 Proteomic-Based Profiling of Lymphomas: Chromatin Proteomics; Composition and Modification of Histone and Non-Histone Chromosomal Proteins Status COMPLETED Phase N/A
NCT01563861 S9704-S0014-S0313A Studying Genes in Samples From Patients With Limited or Advanced Diffuse Large B-Cell Lymphoma Status COMPLETED Phase N/A
NCT01563302 Phase 1/2, Open-label, Dose-escalation Study of IONIS-STAT3Rx, Administered to Patients With Advanced Cancers Status COMPLETED Phase PHASE1/PHASE2
NCT01561911 A Phase I Study of the Chimeric Anti-CD40 Monoclonal Antibody ChiLob 7/4 to Treat Advanced Malignancies Refractory to Conventional Anti-cancer Treatment Status COMPLETED Phase PHASE1
NCT01557881 Positron Emission Tomography/Magnetic Resonance Imaging in Patients Status TERMINATED Phase NA
NCT01551628 A Pilot Study of Recombinant Human Arginase 1 (rhArg1) in Patients With Relapsed or Refractory Leukemia or Lymphoma Status TERMINATED Phase PHASE1
NCT01540175 Immune Reconstitution in Oncology Patients Following Autologous Stem Cell Transplant Status COMPLETED Phase N/A
NCT01538472 Y Zevalin and BEAM in Autologous Stem Cell Transplantation (ASCT) for Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT01532635 A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives Status TERMINATED Phase PHASE2
NCT01528865 Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in Lymphoma Status WITHDRAWN Phase PHASE1/PHASE2
NCT01527422 Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Rituximab Pateinets With Aggresive NHL Status COMPLETED Phase PHASE1/PHASE2
NCT01521611 Targeted Radiotherapy in HSCT for Poor Risk Haematological Malignancy Status COMPLETED Phase PHASE1/PHASE2
NCT01520246 Gene Expression in Samples From Patients With T-Cell Acute Lymphoblastic Leukemia Status COMPLETED Phase N/A